RxDoctor Payments DataLook up a doctor →

Linda Jager, MD

Family Medicine · Davenport, IANPI 1184917981

Payments from drug & device makers

$7,029in general payments, 2019–2025

Across 339 payments — averaging $20.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • Novartis$462
  • AstraZeneca$452
  • Daiichi Sankyo Inc.$423
  • Seagen Inc.$339
  • Amgen$293
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$6,81597%
  • Education$2143%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.23$1,210
Novartis37$462
AstraZeneca(2 entities)22$452
Daiichi Sankyo Inc.20$423
Seagen Inc.17$339
Amgen16$293
Johnson & Johnson(2 entities)28$259
Exelixis Inc.8$257
Genentech USA, Inc.4$252
Bristol Myers Squibb13$243
Merck11$172
Sanofi6$171
E.r. Squibb & Sons, L.L.C.9$144
Puma Biotechnology, Inc.8$130
Myovant Sciences Inc.2$102
Angiodynamics, Inc.1$94
Lilly USA, LLC5$92
Takeda Pharmaceuticals U.S.A., Inc.5$91
Eisai Inc.5$81
Pharmacyclics LLC, An Abbvie Company3$80
Tactile Systems Technology Inc5$80
Taiho Oncology, Inc.4$75
Incyte Corporation5$74
Regeneron Healthcare Solutions, Inc.3$74
GSK4$71
Pfizer4$71
EUSA Pharma (US) LLC1$71
Smith+Nephew4$65
Blueprint Medicines Corporation3$63
Ipsen Biopharmaceuticals, Inc4$63
Mylan Institutional Inc.4$61
Pharmaessentia USA Corporation3$57
Astellas Pharma US Inc3$55
Gilead(2 entities)4$54
Bayer3$49
Convatec Inc.2$44
Beigene USA, Inc.3$43
Urgo Medical North America, LLC2$40
Nestle Healthcare Nutrition Inc.3$39
Servier Pharmaceuticals LLC2$38
Sobi, Inc1$38
EMD Serono, Inc.2$32
Aroa Biosurgery Incorporated1$27
Jazz Pharmaceuticals Inc.2$27
Array Biopharma Inc2$26
Agios Pharmaceuticals, Inc.2$26
Octapharma USA, Inc.1$20
Sanofi-aventis U.S. LLC1$20
Acrotech Biopharma Inc.1$19
Cvrx, Inc.1$18
ADMA Biomanufacturing LLC1$18
Rigel Pharmaceuticals, Inc.1$18
Recordati_rare_diseases_inc.1$17
Sun Pharmaceutical Industries Inc.1$17
ADC Therapeutics America, Inc.1$16
Helsinn Therapeutics (U.S.), Inc.1$15
G1 Therapeutics, Inc.1$15
Medline Industries LP1$15
AMAG Pharmaceuticals, Inc.1$15
CTI Biopharma Corp.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,029 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa →

Medicare billing

Part B allowed, 2024
$7,821
Medicare patients
22
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Davenport

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →